Modifying PEST for Psoriatic Arthritis Screening
Conditions
Plaque Psoriasis · Psoriatic Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Calgary, Alberta, Canada
Novartis Investigative Site, Edmonton, Alberta, Canada
Novartis Investigative Site, Edmonton, Alberta, Canada
Novartis Investigative Site, Kelowna, British Columbia, Canada
Novartis Investigative Site, Surrey, British Columbia, Canada
Novartis Investigative Site, Winnipeg, Manitoba, Canada
Novartis Investigative Site, Fredericton, New Brunswick, Canada
Novartis Investigative Site, Barrie, Ontario, Canada
Novartis Investigative Site, Greater Sudbury, Ontario, Canada
Novartis Investigative Site, Hamilton, Ontario, Canada
Novartis Investigative Site, Hamilton, Ontario, Canada
Novartis Investigative Site, Hamilton, Ontario, Canada
Novartis Investigative Site, London, Ontario, Canada
Novartis Investigative Site, London, Ontario, Canada
Novartis Investigative Site, Markham, Ontario, Canada
Novartis Investigative Site, Ottawa, Ontario, Canada
Novartis Investigative Site, Richmond Hill, Ontario, Canada
Novartis Investigative Site, Stoney Creek, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Waterloo, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Québec, Quebec, Canada
Novartis Investigative Site, Québec, Quebec, Canada
Novartis Investigative Site, Ste-Foy, Quebec, Canada
Novartis Investigative Site, Verdun, Quebec, Canada
Novartis Investigative Site, Saskatoon, Saskatchewan, Canada
Novartis Investigative Site, Saskatoon, Saskatchewan, Canada
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals